FacebookTwitterLinkedIn
here:focus-papers:0
Read More

Assessing the Cardiovascular Safety of Novel Diabetes and Obesity Medications – Implications for Early Phase Development

here:focus-papers:1
Read More

Current and Future Perspectives on the Development of Biosimilar Insulins for Diabetes Management

here:focus-papers:2
Read More

Development Considerations for Biosimilar Insulin Delivery Devices

here:focus-papers:3
Read More

Recruitment Considerations for Early Phase Clinical Trials in Diabetes

here:focus-papers:4
Read More

Considerations for Evaluating the Cardiovascular Safety of Novel Treatments for Diabetes

here:focus-papers:5
Read More

Metabolic Pharmacotherapy for NAFLD/NASH: A Collaborative Approach to Finding New Treatments

in cat NOT

Learn about ProSciento services for COVID-19 clinical studies in healthy subjects